Results 221 to 230 of about 1,303,477 (314)
A binding site for the antibiotic GE81112 in the ribosomal mRNA channel. [PDF]
Schedlbauer A +15 more
europepmc +1 more source
This study systematically investigates the function and molecular mechanisms of YAP phase separation in multiple primary liver cancers. These findings provide novel insights into phase separation‐mediated primary liver cancer development and validate targeted disruption of this process as an effective therapeutic strategy for primary liver cancer ...
Shuang‐Zhou Peng +7 more
wiley +1 more source
Cyclic-di-GMP controls Type III effector export and symptom development in Pseudomonas syringae infections via the export ATPase HrcN. [PDF]
Ward D +3 more
europepmc +1 more source
Gli1+ adventitial stem cells (ASCs) have been thought to generate smooth muscle cells (SMCs) in atherosclerosis. Using a dual‐recombinase lineage tracing to exclude ectopic labeling, Wang et al. found that Gli1+ ASCs do not contribute to SMCs in atherosclerotic plaques.
Haixiao Wang +11 more
wiley +1 more source
Towards a unified gating scheme for the CNBD ion channel family. [PDF]
Lin JL, Chanda B.
europepmc +1 more source
Coupling Nitrogenous Organic Wastewater Treatment and Biorefinery via N‐Cycling Bacterium
The vast reservoir of nitrogenous organic pollutants in industrial wastewaters can serve as untapped carbon‐nitrogen resources. This study employs the newly discovered Paracoccus sp. ZQW‐1 as a versatile chassis to simultaneously achieve N‐methylpyrrolidone (NMP) wastewater depuration and polyhydroxybutyrate (PHB) synthesis.
Ziqian Wang +3 more
wiley +1 more source
PDE10A as a novel diagnostic and therapeutic target in cancer: insights and challenges. [PDF]
Ghoflchi S +4 more
europepmc +1 more source
Multiomic profiling of HER2‐low breast cancer identifies three proteomic subtypes with distinct therapeutic strategies: endocrine, antiangiogenic, and anti‐HER2 therapies. Genomic and lactate modification landscapes are detailed, providing insights for precise management.
Shouping Xu +20 more
wiley +1 more source

